Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid proteomic profiling in nusinersen‐treated patients with spinal muscular atrophy
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-01-06
DOI
10.1111/jnc.14953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neurotrophic, Gene Regulation, and Cognitive Functions of Carboxypeptidase E-Neurotrophic Factor-α1 and Its Variants
- (2019) Lan Xiao et al. Frontiers in Neuroscience
- Radiation exposure of image-guided intrathecal administration of nusinersen to adult patients with spinal muscular atrophy
- (2019) D. Oldenburg et al. NEURORADIOLOGY
- Nusinersen in later-onset spinal muscular atrophy
- (2019) Basil T. Darras et al. NEUROLOGY
- Neurofilament as a potential biomarker for spinal muscular atrophy
- (2019) Basil T. Darras et al. Annals of Clinical and Translational Neurology
- Nusinersen in type 1 spinal muscular atrophy: Twelve‐month real‐world data
- (2019) Marika Pane et al. ANNALS OF NEUROLOGY
- Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen
- (2019) Stefan Gingele et al. Frontiers in Neurology
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- The therapeutic potential of RNA regulation in neurological disorders
- (2018) Jolien Roovers et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patients
- (2018) Claudia D. Wurster et al. JOURNAL OF NEUROLOGY
- Evidence in focus: Nusinersen use in spinal muscular atrophy
- (2018) David Michelson et al. NEUROLOGY
- Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS
- (2018) Michael S. Bereman et al. Scientific Reports
- Treating rare disorders: time to act on unfair prices
- (2017) The Lancet Neurology LANCET NEUROLOGY
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Intrinsic Transcriptional Program Underlying Synaptic Scaling during Activity Suppression
- (2017) Katie Schaukowitch et al. Cell Reports
- Principal component analysis: a review and recent developments
- (2016) Ian T. Jolliffe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome
- (2015) Yang Zhang et al. Journal of Proteomics
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure
- (2013) Susanne Abdulla et al. JOURNAL OF NEUROLOGY
- Cadherins and neuropsychiatric disorders
- (2012) Christoph Redies et al. BRAIN RESEARCH
- The Proteomics Identifications (PRIDE) database and associated tools: status in 2013
- (2012) Juan Antonio Vizcaíno et al. NUCLEIC ACIDS RESEARCH
- Validation of the Expanded Hammersmith Functional Motor Scale in Spinal Muscular Atrophy Type II and III
- (2011) Allan M. Glanzman et al. JOURNAL OF CHILD NEUROLOGY
- Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
- (2010) Sarah Jesse et al. JOURNAL OF NEUROLOGY
- Spinal muscular atrophy
- (2008) Mitchell R Lunn et al. LANCET
- Geometric Interpretation of Gene Coexpression Network Analysis
- (2008) Steve Horvath et al. PLoS Computational Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now